Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Cutting-edge editing techniques are accelerating efforts to create high-yield, resilient varieties of major agricultural products.

But amid all the fervor and history-making lies a few teething issues. Namely, even with the improved specificity CRISPR-Cas9 has brought to gene-editing, accidental, off-target effects still happen.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.